The Modified Shields Classification and 12 Families with Defined DSPP Mutations


Creative Commons License

Simmer J. P., Zhang H., Moon S. J. H., Donnelly L. A., Lee Y., Seymen F., ...Daha Fazla

GENES, cilt.13, sa.5, 2022 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 13 Sayı: 5
  • Basım Tarihi: 2022
  • Doi Numarası: 10.3390/genes13050858
  • Dergi Adı: GENES
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, BIOSIS, CAB Abstracts, Chemical Abstracts Core, EMBASE, MEDLINE, Veterinary Science Database, Directory of Open Access Journals
  • Anahtar Kelimeler: dentinogenesis imperfecta, Shields Classification, DSPP mutations, dentin dysplasia, enamel malformations, whole-exome sequencing (WES), Single Molecule Real-Time (SMRT) DNA sequencing, DENTIN SIALOPHOSPHOPROTEIN MUTATION, PHOSPHOPROTEIN FRAMESHIFT MUTATIONS, RAT-INCISOR DENTIN, IMPERFECTA TYPE-II, DENTINOGENESIS IMPERFECTA, OSTEOGENESIS IMPERFECTA, ENDOPLASMIC-RETICULUM, OPALESCENT DENTIN, GENE, SIALOPROTEIN
  • İstanbul Üniversitesi Adresli: Evet

Özet

Mutations in Dentin Sialophosphoprotein (DSPP) are known to cause, in order of increasing severity, dentin dysplasia type-II (DD-II), dentinogenesis imperfecta type-II (DGI-II), and dentinogenesis imperfecta type-III (DGI-III). DSPP mutations fall into two groups: a 5 '-group that affects protein targeting and a 3 '-group that shifts translation into the -1 reading frame. Using whole-exome sequence (WES) analyses and Single Molecule Real-Time (SMRT) sequencing, we identified disease-causing DSPP mutations in 12 families. Three of the mutations are novel: c.53T>C/p.(Val18Ala); c.3461delG/p.(Ser1154Metfs*160); and c.3700delA/p.(Ser1234Alafs*80). We propose genetic analysis start with WES analysis of proband DNA to identify mutations in COL1A1 and COL1A2 causing dominant forms of osteogenesis imperfecta, 5 '-DSPP mutations, and 3 '-DSPP frameshifts near the margins of the DSPP repeat region, and SMRT sequencing when the disease-causing mutation is not identified. After reviewing the literature and incorporating new information showing distinct differences in the cell pathology observed between knockin mice with 5 '-Dspp or 3 '-Dspp mutations, we propose a modified Shields Classification based upon the causative mutation rather than phenotypic severity such that patients identified with 5 '-DSPP defects be diagnosed as DGI-III, while those with 3 '-DSPP defects be diagnosed as DGI-II.